IDEAS home Printed from https://ideas.repec.org/a/adp/jgjpps/v7y2019i3p83-87.html
   My bibliography  Save this article

Carphedon at the Crossroads: A Dangerous Drug or a Promising Psychopharmaceutical?

Author

Listed:
  • Jiri Patocka

    (Faculty of Health and Social Studies, University of South Bohemia České Budějovice, Czech Republic
    Biomedical Research Centre, University Hospital, Czech Republic)

Abstract

Carphedon is a phenyl derivative of the nootropic drug piracetam (Nootropil) and is effective in increasing physical endurance and cold resistance and is used for amnesia treatment. It was developed in Russia as a stimulant to keep astronauts awake on long missions, and occasionally used in Russia as a nootropic prescription for various types of neurological disease. It became well known a couple years ago when a leading nootropic supplier in California started selling it on the Internet as a supplement and a bunch of athletes got kicked out of the Olympics for illegal using it. Carphedon was found to activate the operant behavior more powerfully, to remove psychodepressant effects of diazepam, to inhibit post-rotational nystagmus, and to prevent the development of retrograde amnesia. Unlike piracetam, carphedon exhibits a specific anticonvulsant action. When given in high doses, produces psychodepressant effects. It is also claimed to increase physical stamina and provide improved tolerance to cold. As a result, it appears on the lists of banned substances issued by the World Anti-Doping Agency.

Suggested Citation

  • Jiri Patocka, 2019. "Carphedon at the Crossroads: A Dangerous Drug or a Promising Psychopharmaceutical?," Global Journal of Pharmacy & Pharmaceutical Sciences, Juniper Publishers Inc., vol. 7(3), pages 83-87, May.
    • Handle: RePEc:adp:jgjpps:v:7:y:2019:i:3:p:83-87
    DOI: 10.19080/GJPPS.2019.07.555713
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555713.pdf
    Download Restriction: no
    File URL: https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555713.php
    Download Restriction: no
    File URL: https://libkey.io/10.19080/GJPPS.2019.07.555713?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:jgjpps:v:7:y:2019:i:3:p:83-87. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.